Literature DB >> 3006155

Interaction of [125I]-Tyr4-bombesin with specific receptors on normal human pancreatic membranes.

J L Scemama, A Zahidi, D Fourmy, P Fagot-Revurat, N Vaysse, L Pradayrol, A Ribet.   

Abstract

The binding of bombesin to its receptors on normal human pancreatic membranes was investigated using high specific activity, radioiodinated bombesin ([125I]-Tyr4-bombesin), prepared by an oxidative method with chloramine-T. Binding was specific, temperature-dependent, saturable, reversible and linearly related to membranes protein concentration. After a 30 min period of incubation with membranes the degradation of the tracer has never been found superior to 20%. Scatchard analysis of binding data was compatible with a single class of binding sites with a high affinity (0.96 nM) and a Bmax of 753 fmol/mg protein. [125I]-Tyr4-bombesin binding to human pancreatic membranes was competitively inhibited by (1-Tyr4-)bombesin, GRP, the nonapeptide of bombesin and litorin but not by unrelated hormones such as somatostatin, CCK, human gastrin, etc. These results describe for the first time the presence of specific receptors for bombesin on human pancreatic membranes. The binding characteristics obtained are comparable with those found in other species.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3006155     DOI: 10.1016/0167-0115(86)90220-x

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  5 in total

1.  Bombesin receptor in membranes from Swiss 3T3 cells. Binding characteristics, affinity labelling and modulation by guanine nucleotides.

Authors:  J Sinnett-Smith; W Lehmann; E Rozengurt
Journal:  Biochem J       Date:  1990-01-15       Impact factor: 3.857

2.  High-affinity binding sites for bombesin on mouse colonic mucosal membranes.

Authors:  S Narayan; E Draviam; S Rajaraman; P Singh
Journal:  Mol Cell Biochem       Date:  1991-07-24       Impact factor: 3.396

3.  Pancreatic polypeptide secretion in patients with chronic pancreatitis and after pancreatic surgery.

Authors:  E H Eddes; M Verkijk; H A Gielkens; I Biemond; W Bemelman; C B Lamers; A A Masclee
Journal:  Int J Pancreatol       Date:  2001

4.  Molecular imaging, pharmacokinetics, and dosimetry of In-AMBA in human prostate tumor-bearing mice.

Authors:  Chung-Li Ho; I-Hsiang Liu; Yu-Hsien Wu; Liang-Cheng Chen; Chun-Lin Chen; Wan-Chi Lee; Cheng-Hui Chuang; Te-Wei Lee; Wuu-Jyh Lin; Lie-Hang Shen; Chih-Hsien Chang
Journal:  J Biomed Biotechnol       Date:  2011-05-24

5.  Expression of receptors for gut peptides in human pancreatic adenocarcinoma and tumour-free pancreas.

Authors:  C Tang; I Biemond; G J Offerhaus; W Verspaget; C B Lamers
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.